Guest guest Posted November 16, 2003 Report Share Posted November 16, 2003 Mon, 17 Nov 2003 00:12:41 -0500 HSI - Jenny Thompson Fooling Mother Nature Fooling Mother Nature Health Sciences Institute e-Alert November 17, 2003 ************************************************************** Dear Reader, Last week I got an e-mail from a friend of mine, Paul, who was very excited to tell me about a recent study he'd seen. There's a good chance you read about it too. Using a synthetic form of the so-called " good cholesterol, " high density lipoprotein (HDL), researchers at the Cleveland Clinic apparently reduced arterial plaque in subjects with heart disease. Paul was excited by this study for three reasons. 1) He's constantly having to listen to me talk about studies I've seen and was happy to be doing the talking for a change; 2) he tends to have low HDL levels and he's convinced this puts him at high risk of plaque building up in his arteries; and 3) most of the media reports on this study fairly gushed with optimistic excitement, using words like " milestone, " and " landmark. " I didn't tell Paul this (yet), but, in fact, this study is not a real milestone, and it's far from a landmark. It does, however, provide us with a good opportunity to recognize the true role that HDL plays in the risk of heart disease. And contrary to what many nutritionists will tell you, it's NOT the result of saturated fat intake. ---------------------------- Big " if " ---------------------------- " Extremely preliminary " is how Susan K. Bennett (clinical director of the George Washington University Hospital Women's Heart Program) described the Cleveland Clinic study to the Washington Post. In other words: Let's not get carried away. Headed up by the Cleveland Clinic, researchers at 10 hospitals around the U.S. recruited 47 patients with acute coronary syndromes. Subjects were split into three groups and received weekly injections of placebo, or injections of the synthetic HDL (called ETC-216) at 15 mg/kg or 45 mg/kg. Using ultrasound techniques, accumulation of arterial plaque was measured at the start of the study, and at the conclusion, five weeks later. The results: On average, plaque increased by a very small fraction of one percent in the placebo subjects. But among those receiving ETC-216, arterial plaque decreased on average by just over one percent. Apparently no adverse side effects were reported, but for extended use of such a treatment, that has to be a concern. As we've seen many times in the past, there are almost always repercussions for fooling Mother Nature with synthetic agents. So while this outcome is intriguing, is it really a " milestone " ? That would be completely overstating the significance of a brief study using only a small group of patients. If you've been reading the e-Alert for a while, it will come as no surprise that many research projects are funded by the manufacturers of the products tested. And that's the case here, with the manufacturer of ETC-216, Esperion Therapeutics, Inc., providing the complete financial backing. Encouraged by the Cleveland Clinic results, Esperion executives say they're now planning a one-year study with " thousands " of patients. If they come up with the same results, and no adverse side effects, then they may actually have a milestone on their hands. That's a big " if. " And at least one doctor believes that it's not going to happen because it would be completely contrary to the way HDL is known to perform. ---------------------------- Hat is not on the menu ---------------------------- While researching the Cleveland Clinic study, I found literally hundreds of Internet sources that had picked up the basic details of the report and, without questioning, sang the praises of this synthetic HDL " breakthrough. " The one refreshing - and thoroughly logical - voice of reason I was able to find came from Malcolm Kendrick, M.D., a columnist for the web site Red Flags Daily. With a few deft strokes, Dr. Kendrick, explains how HDL recycles cholesterol in the body, and why it simply isn't capable of clearing out arterial plaque. As I've written in previous e-Alerts, body cells use cholesterol to perform several chores that are essential to good health. When cells break down, they release cholesterol, which HDL collects and carries to the liver. Many doctors and researchers have theorized that HDL can also collect cholesterol from arterial plaques. Dr. Kendrick points out that HDL is what he calls a " passive, inanimate chemical " that collects free-floating cholesterol, but by its nature is incapable of aggressively extracting cholesterol from plaque. So can Esperion's synthetic HDL manage to do what normal HDL can't? Dr. Kendrick strongly suspects it can't. He adds that if it can he'll eat his hat. And he'll be looking forward (as we will) to the results of further studies. Dr. Kendrick also notes that low HDL is a marker for high levels of very low density lipoproteins (VLDLs). This is significant because raised VLDL is a marker for insulin resistance, which is one of the causes of heart disease. So while HDL levels don't have a direct effect on arterial plaque, low HDL is an important indicator of a potentially dangerous pre-diabetic condition. ---------------------------- Halfway there ---------------------------- According to previous studies, combining regular exercise with a low-carbohydrate diet is a good way to raise HDL levels. And of course this is also the best way to prevent type 2 diabetes. Paul, who's concerned about his low HDL levels, is one of the most devoted exercisers I've ever known. But he's also just as passionately devoted to the mainstream notion that a high-fiber, low-fat diet is the best way to prevent plaque buildup and artery disease. He's got the exercise half of the equation right. I have to think that if he tried changing his dietary views - and his diet - for a few months, he just might solve his HDL problem. But who am I to tell him that? ************************************************************** To start receiving your own copy of the HSI e-Alert, visit: http://www.hsibaltimore.com/ealert/freecopy.html Or forward this e-mail to a friend so they can sign-up to receive their own copy of the HSI e-Alert. ************************************************************** ... and another thing The U.S. Senate can be a tough nut to crack. That's what an HSI member named Josephine found out when she tried to get through to several senators after reading the e-Alert " Under the Gun " (11/10/03) about two senate bills proposing changes to the Dietary Supplement Health and Education Act (DSHEA). The problem: several of Josephine's e-mails bounced back as undeliverable. She also says, " I went to the senate bill page and put in Senate Bill S 722 and S 1538, which were the topics of today's HSI newsletter, but those bills never came up. Bills other than health bills had those numbers. Could there be some mistake? " Why the e-mail addresses listed at congress.org might be out of service, I couldn't say. But if the e-mail won't go through, try sending a letter by snail mail instead. It's not quite as fast and easy, but it will probably get more attention than an e-mail. As for reading the text of a current bill - those can be hard to find on the congress.org site. An easier place to look for bills is the Library of Congress web site: loc.gov. On the LOC home page, click on " Thomas / Legislative Information. " That will take you to a page where you can enter any bill number for a quick link to the full text and status of the bill. So be like Josephine and exercise your voice! Tell your Senators that you strongly support S. 1538 ( " DSHEA Full Implementation and Enforcement Act " ) which will provide all the funding necessary to insure consumer protection under DSHEA. Tell them you hope they'll support S. 1538, while also opposing S. 722 ( " Dietary Supplement Safety Act of 2003 " ), which will only limit our freedom to make our own health care choices with the responsible use of dietary supplements. To Your Good Health, Jenny Thompson Health Sciences Institute ************************************************************** Sources: " Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes " Journal of the American Medical Association, vol. 290, no. 17, 11/5/03, jama.ama-assn.org " Liquid Drano-Like Synthetic " Good Cholesterol " Plaque Buster! It's Science, but Not as We Know it " Malcom Kendrick, M.D., Red Flags Daily, 11/6/03, redflagsweekly.com " Synthetic 'Good' Cholesterol Helps Clear Arteries " Rob Stein, Washington Post, 11/5/03, washingtonpost.com " Researchers: Raising HDL Levels Might Reverse Heart Disease " WBAL TV, 11/4/03, thebalchannel.com " Cholesterol Treats Heart Disease " BBC News, 11/5/03, news.bbc.co.uk Copyright ©1997-2003 by www.hsibaltimore.com, L.L.C. The e-Alert may not be posted on commercial sites without written permission. ************************************************************** Before you hit reply to send us a question or request, please visit here http://www.hsibaltimore.com/ealert/questions.html ************************************************************** If you'd like to participate in the HSI Forum, search past e-Alerts and products or you're an HSI member and would like to search past articles, visit http://www.hsibaltimore.com ************************************************************** To learn more about HSI, call (203) 699-4416 or visit http://www.agora-inc.com/reports/HSI/WHSID618/home.cfm. ************************************************************** To manage your e-mail subscription, use our web interface at: http://www.agoramail.net/Home.cfm?List=hsiweb Or to end your e-mail subscription, send a blank e-mail to: hsiweb_unsub To cancel or for any other subscription issues, write us at: Order Processing Center Attn: Customer Service P.O. Box 925 Frederick, MD 21705 NEW WEB MESSAGE BOARDS - JOIN HERE. Alternative Medicine Message Boards.Info http://alternative-medicine-message-boards.info Protect your identity with Mail AddressGuard Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.